G37.81 - Myelin oligodendrocyte glycoprotein antibody disease
- Applicable to Myelin oligodendrocyte glycoprotein antibody disease
- The 2025 edition of ICD10-CM G37.81 became effective on October 1, 2024.
- This is the American ICD10-CM version of G37.81 - other international versions of ICD10 G37.81 may differ.
- G37.81 is a Billable / Specific ICD10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
Inclusion terms help to clarify and specify the conditions or diseases covered by a particular ICD-10-CM code.
Inclusion Term:
- MOG antibody disease
codeAlso
- associated manifestations, if known, such as:
- noninfectious acute disseminated encephalomyelitis (G04.81)
- neuromyelitis optica (G36.0)
Billable/Specific Code
The following codes above G37.81 contain annotation back-references that may be applicable to G37.81:
- Chapter: G00-G99 - Diseases of the nervous system
- Section: G35-G37 - Demyelinating diseases of the central nervous system
- Category: G37 - Other demyelinating diseases of central nervous system
Browse other similar CM codes:
Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.
Please, give attribution to our website icd10all.com